BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21630316)

  • 1. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
    Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
    Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
    Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM
    Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers.
    Blann AD; Balakrishnan B; Shantsila E; Ryan P; Lip GY
    Prostate; 2011 Jul; 71(10):1047-53. PubMed ID: 21557269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells.
    Strijbos MH; van Krimpen BA; Debets R; Kraan J; Sleijfer S; Gratama JW; Lamers CH
    Thromb Haemost; 2010 Aug; 104(2):318-26. PubMed ID: 20589320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
    Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
    Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells in acute ischaemic stroke.
    Nadar SK; Lip GY; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):707-12. PubMed ID: 16270621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
    Brunner S; Theiss HD; Murr A; Negele T; Franz WM
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis.
    Watson T; Shantsila E; Blann A; Lip GY
    Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score.
    Federici AB; Barillari G; Zanon E; Mazzucconi MG; Musso R; Targhetta R; Mannucci PM
    Haemophilia; 2010 Jan; 16(1):101-10. PubMed ID: 19811543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells in coronary artery disease.
    Lampka M; Grąbczewska Z; Jendryczka-Maćkiewicz E; Hołyńska-Iwan I; Sukiennik A; Kubica J; Halota W; Tyrakowski T
    Kardiol Pol; 2010 Oct; 68(10):1100-5. PubMed ID: 20967702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients.
    Ozkok A; Aktas E; Yilmaz A; Telci A; Oflaz H; Deniz G; Yildiz A
    Clin Nephrol; 2013 Jan; 79(1):21-30. PubMed ID: 22909781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
    Chong AY; Lip GY; Freestone B; Blann AD
    Eur J Heart Fail; 2006 Mar; 8(2):167-72. PubMed ID: 16185922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.